1	Well	well	UH	_	7	intj	7:AM-DIS
2	,	,	,	_	7	punct	_
3	the	the	DT	_	5	det	_
4	last	last	JJ	_	5	amod	_
5	week	week	NN	_	7	nsubj	7:A1=PPT
6	has	have	VBZ	_	7	aux	_
7	gotten	get	VBN	pb=get.03	0	root	_
8	just	just	RB	_	11	advmod	_
9	a	a	DT	_	10	det	_
10	bit	bit	NN	_	11	npadvmod	_
11	better	good	JJR	p2=RBR	7	acomp	7:A2=GOL
12	for	for	IN	_	11	prep	_
13	Bristol	bristol	NNP	_	15	hmod	_
14	-	-	HYPH	_	15	hyph	_
15	Myers	myers	NNP	_	16	nn	_
16	Squibb	squibb	NNP	_	12	pobj	_
17	(	(	-LRB-	_	18	punct	_
18	NYSE	nyse	NNP	_	16	appos	_
19	:	:	:	_	18	punct	_
20	BMY	bmy	NNP	_	18	appos	_
21	)	)	-RRB-	_	18	punct	_
22	thanks	thanks	NNS	_	7	npadvmod	_
23	to	to	IN	_	22	prep	_
24	the	the	DT	_	27	det	_
25	Federal	federal	NNP	_	27	nn	_
26	Drug	drug	NNP	_	27	nn	_
27	Administration	administration	NNP	_	23	pobj	_
28	.	.	.	_	7	punct	_

1	Bristol	bristol	NNP	_	3	hmod	_
2	-	-	HYPH	_	3	hyph	_
3	Myers	myers	NNP	_	4	nsubj	4:A0=PAG
4	won	win	VBD	pb=win.01	0	root	_
5	its	its	PRP$	_	9	poss	_
6	second	#ord#	JJ	_	9	amod	_
7	breakthrough	breakthrough	NN	p2=JJ	8	nn	_
8	therapy	therapy	NN	_	9	nn	_
9	designation	designation	NN	_	4	dobj	4:A1=PPT
10	from	from	IN	_	4	prep	4:A3=DIR
11	the	the	DT	_	12	det	_
12	FDA	fda	NNP	_	10	pobj	_
13	in	in	IN	_	4	prep	_
14	under	under	IN	p2=RB	13	prep	_
15	a	a	DT	_	16	det	_
16	week	week	NN	_	18	poss	_
17	's	's	POS	_	16	possessive	_
18	time	time	NN	_	14	pobj	_
19	.	.	.	_	4	punct	_

1	Just	just	RB	_	2	advmod	_
2	days	day	NNS	_	3	npadvmod	_
3	after	after	IN	_	22	prep	22:AM-TMP
4	getting	get	VBG	pb=get.01	3	pcomp	_
5	the	the	DT	_	6	det	_
6	FDA	fda	NNP	_	9	poss	_
7	's	's	POS	_	6	possessive	_
8	elite	elite	JJ	p2=NN	9	amod	_
9	status	status	NN	_	4	dobj	4:A1=PPT
10	for	for	IN	_	9	prep	_
11	its	its	PRP$	_	17	poss	_
12	closely	closely	RB	_	14	hmod	_
13	-	-	HYPH	_	14	hyph	_
14	watched	watch	VBN	p2=VBD	17	amod	_
15	anti-PD-1	anti-pd-0	JJ	p2=NN	16	amod	_
16	drug	drug	NN	_	17	nn	_
17	Nivolumab	nivolumab	NNP	p2=NN	10	pobj	_
18	,	,	,	_	22	punct	_
19	the	the	DT	_	20	det	_
20	agency	agency	NN	_	22	nsubj	22:A1
21	has	have	VBZ	_	22	aux	_
22	followed	followed	VBN	pb=follow.01	0	root	_
23	up	up	RP	_	22	prt	22:C-V
24	with	with	IN	_	22	prep	22:AM-MNR
25	a	a	DT	_	26	det	_
26	nod	nod	NN	_	24	pobj	_
27	for	for	IN	_	26	prep	_
28	Elotuzumab	elotuzumab	NNP	p2=NN	27	pobj	_
29	.	.	.	_	22	punct	_

1	Elotuzumab	elotuzumab	NNP	p2=EX	2	nsubj	2:A1=PPT
2	is	be	VBZ	pb=be.01	0	root	_
3	an	an	DT	_	4	det	_
4	antibody	antibody	NN	_	2	attr	2:A2=PRD;6:A3=MNR
5	that	that	WDT	p2=IN	6	nsubj	6:R-A3
6	binds	bind	VBZ	pb=bind.01	4	rcmod	_
7	to	to	IN	_	6	prep	6:A2=GOL
8	the	the	DT	_	9	det	_
9	glycoprotein	glycoprotein	NN	_	7	pobj	10:A1=PPT
10	found	find	VBN	p2=VBD|pb=find.01	9	partmod	_
11	on	on	IN	_	10	prep	10:AM-LOC
12	myeloma	myeloma	NN	p2=JJ	13	nn	_
13	cells	cell	NNS	_	19	nn	_
14	and	and	CC	_	13	cc	_
15	"	"	``	_	17	punct	_
16	Natural	natural	NNP	p2=JJ	17	nn	_
17	Killer	killer	NNP	_	13	conj	_
18	"	"	''	_	17	punct	_
19	cells	cell	NNS	p2=VBZ	11	pobj	_
20	in	in	IN	_	10	prep	10:AM-MNR
21	a	a	DT	_	22	det	_
22	way	way	NN	_	20	pobj	24:A0=PPT
23	that	that	WDT	_	24	nsubj	24:R-A0
24	focuses	focus	VBZ	pb=focus.01	22	rcmod	_
25	the	the	DT	_	27	det	_
26	immune	immune	JJ	_	27	amod	_
27	system	system	NN	_	24	dobj	24:A1=PPT
28	on	on	IN	_	27	prep	_
29	killing	kill	VBG	pb=kill.01	28	pcomp	_
30	myeloma	myeloma	NN	_	31	nn	_
31	cells	cell	NNS	_	29	dobj	29:A1=PPT
32	while	while	IN	_	33	mark	_
33	leaving	leave	VBG	pb=leave.01	29	advcl	29:AM-TMP
34	healthy	healthy	JJ	_	35	amod	_
35	cells	cell	NNS	_	33	dobj	33:A1=DIR
36	alone	alone	RB	p2=JJ	33	advmod	33:A2=PRD
37	.	.	.	_	2	punct	_

1	"	"	``	_	11	punct	_
2	Despite	despite	IN	_	11	prep	11:AM-ADV
3	recent	recent	JJ	_	4	amod	_
4	advances	advance	NNS	_	2	pobj	_
5	in the treatment of	in the treatment of	IN	p2=VBP	4	prep	_
6	relapsed	relapse	VBN	p2=JJ|pb=relapse.01	8	amod	_
7	or refractory multiple	or refractory multiple	NNP	p2=JJ	8	nn	_
8	myeloma	myeloma	NN	p2=NNP	5	pobj	6:A1=PPT
9	,	,	,	_	11	punct	_
10	 it	 it	NN	p2=,	11	nsubj	11:A1=PPT
11	remains	remain	VBZ	pb=remain.01	0	root	_
12	an	an	DT	_	13	det	_
13	area	area	NN	_	11	attr	11:A3=PRD
14	of	of	IN	_	13	prep	_
15	unmet	unmet	JJ	p2=NN	16	amod	_
16	need	need	NN	_	14	pobj	_
17	,	,	,	_	11	punct	_
18	"	"	''	p2=``	11	punct	_
19	said Michael	said michael	NNP	p2=IN	20	nn	_
20	Giordano	giordano	NNP	_	13	appos	_
21	,	,	,	_	20	punct	_
22	the	the	DT	_	23	det	_
23	head	head	NN	_	20	appos	_
24	of	of	IN	_	23	prep	_
25	development	development	NN	_	24	pobj	_
26	on	on	IN	_	23	prep	_
27	oncology	oncology	NN	p2=NNS	26	pobj	_
28	and	and	CC	_	27	cc	_
29	immunosciences	immunosciences	NNS	p2=VBZ	27	conj	_
30	at	at	IN	_	29	prep	_
31	Bristol	bristol	NNP	_	33	hmod	_
32	-	-	HYPH	_	33	hyph	_
33	Myers	myers	NNP	_	34	nn	_
34	Squibb	squibb	NNP	_	30	pobj	_
35	.	.	.	_	20	punct	_

1	"	"	``	p2=''	5	punct	_
2	This Breakthrough	this breakthrough	NNP	_	4	nn	_
3	Therapy	therapy	NNP	_	4	nn	_
4	Designation	designation	NNP	p2=NN	5	nsubj	5:A0=PAG;12:A0=PAG
5	underscores	underscore	VBZ	pb=underscore.01	34	ccomp	34:A1=PPT
6	the	the	DT	_	8	det	_
7	potential	potential	JJ	p2=NN	8	amod	_
8	of elotuzumab in	of elotuzumab in	NN	p2=CC	5	dobj	5:A1=PPT
9	this	this	DT	_	10	det	_
10	setting	setting	NN	p2=VBG	5	dobj	5:AM-TMP
11	and	and	CC	_	5	cc	_
12	reinforces	reinforce	VBZ	pb=reinforce.01	5	conj	_
13	Bristol	bristol	NNP	_	15	hmod	_
14	-	-	HYPH	_	15	hyph	_
15	Myers	myers	NNP	_	16	nn	_
16	Squibb	squibb	NNP	_	19	poss	_
17	's	's	POS	_	16	possessive	_
18	longstanding	longstanding	JJ	_	19	amod	_
19	commitment	commitment	NN	_	12	dobj	12:A1=PPT
20	to	to	IN	_	19	prep	_
21	the	the	DT	_	22	det	_
22	research	research	NN	_	20	pobj	_
23	and	and	CC	_	22	cc	_
24	development	development	NN	_	22	conj	_
25	of	of	IN	_	22	prep	_
26	novel	novel	JJ	p2=NN	27	amod	_
27	medicines	medicine	NNS	_	25	pobj	29:A3=MNR
28	to	to	TO	_	29	aux	_
29	treat	treat	VB	pb=treat.03	27	infmod	_
30	hematologic	hematologic	JJ	p2=PRP	31	amod	_
31	malignancies	malignancy	NNS	p2=NN	29	dobj	29:A1=PPT
32	,	,	,	_	34	punct	_
33	"	"	''	_	34	punct	_
34	stated	state	VBD	p2=VBN|pb=state.01	0	root	_
35	Giordano	giordano	NNP	_	34	nsubj	34:A0=PAG
36	.	.	.	_	34	punct	_

1	Bristol	bristol	NNP	_	3	poss	_
2	's	's	POS	_	1	possessive	_
3	stock	stock	NN	_	7	nsubj	7:A1=PPT
4	has	have	VBZ	_	7	aux	_
5	so	so	RB	_	6	advmod	_
6	far	far	RB	_	7	advmod	7:AM-TMP
7	been	be	VBN	pb=be.01	0	root	_
8	unaffected	unaffected	JJ	_	7	acomp	7:A2=PRD
9	by	by	IN	_	8	prep	_
10	this	this	DT	_	12	det	_
11	new	new	JJ	_	12	amod	_
12	designation	designation	NN	_	9	pobj	_
13	after	after	IN	_	7	prep	7:AM-TMP
14	dropping	drop	VBG	pb=drop.01	13	pcomp	_
15	on	on	IN	_	14	prep	14:AM-LOC
16	last	last	JJ	_	17	amod	_
17	week	week	NN	_	19	poss	_
18	's	's	POS	_	17	possessive	_
19	news	news	NN	_	15	pobj	_
20	.	.	.	_	7	punct	_

1	Bristol	bristol	NNP	_	2	nn	_
2	Myers	myers	NNP	_	4	nsubj	4:A1=PPT
3	had	have	VBD	_	4	aux	_
4	rallied	rally	VBN	pb=rally.01	0	root	_
5	nicely	nicely	RB	_	4	advmod	4:AM-MNR
6	from	from	IN	_	4	prep	4:A2=CAU
7	its	its	PRP$	_	12	poss	_
8	$	$	$	_	9	quantmod	_
9	40	0	CD	_	12	nn	_
10	low	low	JJ	p2=NN	12	amod	_
11	last	last	JJ	_	12	amod	_
12	fall	fall	NN	_	6	pobj	_
13	,	,	,	_	4	punct	_
14	yet	yet	RB	p2=CC	16	advmod	16:AM-TMP
15	has	have	VBZ	_	16	aux	_
16	stalled	stall	VBN	pb=stall.01	4	conj	_
17	thus	thus	RB	_	18	advmod	_
18	far	far	RB	_	16	advmod	16:AM-TMP
19	this	this	DT	_	20	det	_
20	year	year	NN	_	16	npadvmod	16:AM-TMP
21	.	.	.	_	4	punct	_

1	Currently	currently	RB	_	5	advmod	5:AM-TMP
2	,	,	,	_	5	punct	_
3	the	the	DT	_	4	det	_
4	stock	stock	NN	_	5	nsubj	5:A1=PAG
5	sits	sit	VBZ	pb=sit.01	0	root	_
6	near	near	IN	_	5	prep	5:A2=LOC
7	its	its	PRP$	_	8	poss	_
8	low	low	NN	_	6	pobj	_
9	for	for	IN	_	5	prep	5:AM-TMP
10	the	the	DT	_	11	det	_
11	year	year	NN	_	9	pobj	_
12	at	at	IN	_	5	prep	5:AM-TMP
13	around	around	IN	_	15	advmod	_
14	$	$	$	_	15	quantmod	_
15	47	0	CD	_	12	pobj	_
16	per	per	IN	_	15	prep	_
17	share	share	NN	_	16	pobj	_
18	.	.	.	_	5	punct	_

1	Investors	investor	NNS	_	3	nsubj	3:A0
2	will	will	MD	_	3	aux	3:AM-MOD
3	hope	hope	VB	pb=hope.01	0	root	_
4	that	that	IN	_	9	complm	_
5	these	these	DT	_	7	det	_
6	new	new	JJ	_	7	amod	_
7	developments	development	NNS	_	9	nsubj	9:A0=PAG
8	might	might	MD	_	9	aux	9:AM-MOD
9	get	get	VB	pb=get.01	3	ccomp	3:A1=PPT
10	the	the	DT	_	11	det	_
11	stock	stock	NN	_	12	nsubj	12:A1=PPT
12	moving	move	VBG	pb=move.01	9	ccomp	9:A1=PPT
13	higher	high	JJR	p2=RBR	12	advmod	12:AM-DIR
14	again	again	RB	_	12	advmod	12:AM-TMP
15	.	.	.	_	3	punct	_

1	Bristol	bristol	NNP	_	6	poss	_
2	's	's	POS	_	1	possessive	_
3	52	0	CD	_	5	hmod	_
4	-	-	HYPH	_	5	hyph	_
5	week	week	NN	_	6	nn	_
6	high	high	NN	p2=JJ	8	nsubj	8:A1=PAG
7	currently	currently	RB	_	8	advmod	8:AM-TMP
8	sits	sit	VBZ	pb=sit.01	0	root	_
9	at	at	IN	_	8	prep	8:A2=LOC
10	around	around	IN	_	12	quantmod	_
11	$	$	$	_	12	quantmod	_
12	57	0	CD	_	9	pobj	16:A1=GOL
13	,	,	,	_	12	punct	_
14	which	which	WDT	_	16	nsubjpass	16:R-A1
15	was	be	VBD	_	16	auxpass	_
16	hit	hit	VBN	pb=hit.01	12	rcmod	_
17	in	in	IN	_	16	prep	16:AM-TMP
18	March	march	NNP	_	17	pobj	_
19	of	of	IN	_	18	prep	_
20	this	this	DT	_	21	det	_
21	year	year	NN	_	19	pobj	_
22	.	.	.	_	8	punct	_

1	The	the	DT	_	2	det	_
2	company	company	NN	_	6	poss	_
3	's	's	POS	p2=VBZ	2	possessive	_
4	next	next	JJ	_	6	amod	_
5	earnings	earnings	NNS	_	6	nn	_
6	report	report	NN	_	7	nsubj	7:A1=PPT
7	is	be	VBZ	pb=be.01	0	root	_
8	due	due	JJ	_	7	acomp	7:A2=PRD
9	on	on	IN	_	8	prep	_
10	July	july	NNP	_	9	pobj	_
11	24	0	CD	_	10	num	_
12	,	,	,	_	10	punct	_
13	2014	0	CD	_	10	num	_
14	.	.	.	_	7	punct	_

